Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Anjeni Keswani"'
Autor:
Rachel Peterson, Anjeni Keswani
Publikováno v:
American Journal of Rhinology & Allergy. 37:147-152
Background/Objective Multiple factors affect healthcare disparities in chronic rhinosinusitis (CRS) with and without nasal polyps. These factors include access to care, economic burdens to treatment, and differences in air pollution and air quality.
Biologics for Nasal Polyps: Synthesizing Current Recommendations into a Practical Clinical Algorithm
Publikováno v:
American Journal of Rhinology & Allergy. 37:207-213
Background Chronic rhinosinusitis with nasal polyps (CRSwNP) has been traditionally managed with a combination of topical and systemic medical therapy as well as endoscopic sinus surgery. The emergence of biologic therapies that target specific aspec
Autor:
Jamie A. Rosenthal, Michelle Premazzi Papa, Marta Sanz, Samuel Nicholes, Carissa S. Holmberg, Alberto Bosque, Anjeni Keswani, Richard Amdur, Rebecca M. Lynch, Natalia Soriano-Sarabia, Daniel Ein
Publikováno v:
Annals of Allergy, Asthma & Immunology.
Publikováno v:
Allergy & Rhinology, Vol 9 (2018)
Introduction A 79-year-old woman with macular degeneration was referred to the Allergy/Immunology clinic for the evaluation of a potential allergy to anti-vascular endothelial growth factor (anti-VEGF) treatments. The patient developed urticaria and
Externí odkaz:
https://doaj.org/article/8a1228d690bc45fcbfe072b96608a5a8
Publikováno v:
American Journal of Rhinology & Allergy. 37:130-131
Publikováno v:
Annals of Allergy, Asthma & Immunology. 128:223-225
Autor:
Seong H. Cho, Anil Nanda, Anjeni Keswani, Allen Adinoff, Fuad M. Baroody, Jonathan A. Bernstein, Alina Gherasim, Joseph K. Han, Jerald W. Koepke, Dennis K. Ledford, Amber N. Pepper, Carmen Rondón, Amy Schiffman, Martin Wagenmann, Paloma Campo
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:1215-1222.e4
Publikováno v:
NEJM Evidence. 1
Autor:
John V. Bosso, Andrew A. White, Elina Jerschow, Tanya M. Laidlaw, Whitney W. Stevens, Joshua M. Levy, Seong H. Cho, Alan P. Baptist, Paloma Campo, Katherine N. Cahill, Anil Nanda, Kathleen M. Buchheit, Anjeni Keswani, Larry Borish
Publikováno v:
J Allergy Clin Immunol
Aspirin-exacerbated respiratory disease (AERD) is characterized by the clinical triad of chronic rhinosinusitis with nasal polyps, asthma, and an intolerance to medications that inhibit the cycloxgenase-1 enzyme. Patients with AERD on average have mo
Publikováno v:
Annals of Allergy, Asthma & Immunology. 127:269-271